The Santiago Health Research Institute (Instituto de Investigación Sanitaria de Santiago de Compostela – IDIS), led by Professor José Castillo, will coordinate for the next three years the main platform of the European Atlantic region to innovate in the diagnosis and treatment of high-impact neurological diseases, especially strokes and Alzheimer.
The project, which will run until at least 2022 and endowed with a budget of 1.8 million, will count with more than fifty European researchers, and will be led by the Clinical Neuroscience and Molecular Image Groups of the Compostela Institute.
According to sources from the Institute, the hiring of four researchers at the Santiago University Hospital Complex (CHUS) is contemplated.
This is the first European Interreg Atlantic project coordinated by researchers from the Servizo Galego de Saúde – Doctors Tomás Sobrino and Pablo Aguiar, the latter coordinated by Professor Álvaro Ruibal. Despite the fact that the initiative is coordinated from the Galician capital, they participate together with researchers from Santiago, the United Kingdom, France, Portugal and the rest of Spain.
The manager of the Integrated Management of Santiago, Eloína Núñez, has participate in the presentation and inauguration of the NeuroAtlantic research project, in an act that took place at the Clinical Hospital, and in which she stressed that “our institution is at the forefront for years in the field of innovation and research associated with active aging in neurological diseases “.
The main researchers of the project consider that the possibility of bringing together the great scientific and technological capabilities in the European Atlantic area in the field of neurological diseases associated with aging, of great impact in this area, will result in a “more effective diagnosis and treatment ” and will establish new therapeutic options and preventive measures in the evolution of these ailments, consequently improving both the prognosis and the evolution of the condition and the quality of life of the patient.
Also, the clinical, social and economic impact of the project have been highlighted.